1 C
London
Saturday, November 23, 2024
HomeTagsImmunai

Tag: Immunai

spot_imgspot_img

Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform

Immunai, a New York-based biotech company, today announced a $215M Series B, increasing the companyÂ’s total funding to date to $295M. The new capital...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

spot_img